Trial Profile

Phase 1 clinical study of BHV-8000

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 27 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BHV-8000 (Primary)
Indications CNS disorders
Focus Adverse reactions

Most Recent Events

12 Nov 2024 According to a Biohaven media release, the company plans to completed this study in the coming months.
29 May 2024 According to a Biohaven media release, positive results from this study were presented in a financial report.
09 May 2024 According to a Biohaven media release, complete SAD/MAD studies with BHV-8000 and advance to Phase 2 in 2H 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com